Physician

Peter Rosandich, M.D.

According to 2025 Medicare claims, Peter Rosandich, M.D. (NPI: 1356435747) practices rheumatology in the Albuquerque, NM market, with the plurality of this provider's patient population coming from Bernalillo, NM. This provider's primary affiliated billing organization is NEW MEXICO RHEUMATOLOGY, LLC (NPI: 1164754453; TIN: 27-1996927) and primary practice location at 87113-2105. Rosandich is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Rosandich's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 110 traditional Medicare patients, billed 51,140 HCPCS/CPT codes, and received $1,061,247 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 804 prescription claims across 116 beneficiaries totaling $507,103 in drug costs, led by Enbrel Sureclick (Etanercept). Open Payments data shows 8 records totaling $144. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $595,615 to $1,061,247. Similarly, Part D prescription costs have moved sharply higher in recent years, from $348,002 to $507,103. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.